Literature DB >> 15086554

Functional CCR9 expression is associated with small intestinal metastasis.

Anne Letsch1, Ulrich Keilholz, Dirk Schadendorf, Geraldine Assfalg, Anne Marie Asemissen, Eckhard Thiel, Carmen Scheibenbogen.   

Abstract

In general, metastases to the small intestine are rare, and mostly occur in melanoma. CCR9 has been shown to be the principal chemokine receptor for the thymus expressed chemokine (TECK), a chemokine selectively expressed in the small intestine and thymus. Here we show that CCR9 is highly expressed on melanoma cells and all melanoma cell lines isolated from small intestinal metastases, and on a proportion of cell lines from other sites. Only melanoma cells and cell lines from small intestinal metastases, however, were responsive to the CCR9 ligand TECK, as assessed by receptor downregulation and by actin polymerization. CCR9 expression was also found on the adenocarcinoma cell line CaCo-2 expressing characteristics of enterocytic differentiation, but not on any other cell line isolated from colorectal, breast, and lung cancer. Our data provide evidence that the aberrant functional cell surface expression of an organ-specific chemokine receptor is associated with metastasis to this site. The regulation of receptor function seems to be a critical step in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086554     DOI: 10.1111/j.0022-202X.2004.22315.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  38 in total

1.  Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

Authors:  Rajesh Singh; Cecil R Stockard; William E Grizzle; James W Lillard; Shailesh Singh
Journal:  Int J Oncol       Date:  2011-05-31       Impact factor: 5.650

Review 2.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  CCR9:CCL25 in melanoma metastatic to small intestine.

Authors:  Kim A Margolin
Journal:  Curr Oncol Rep       Date:  2009-09       Impact factor: 5.075

Review 4.  Homeostatic chemokine receptors and organ-specific metastasis.

Authors:  Albert Zlotnik; Amanda M Burkhardt; Bernhard Homey
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

5.  TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.

Authors:  Francesca Coperchini; Patrizia Pignatti; Andrea Carbone; Rossana Bongianino; Christian A Di Buduo; Paola Leporati; Laura Croce; Flavia Magri; Alessandra Balduini; Luca Chiovato; Mario Rotondi
Journal:  Tumour Biol       Date:  2015-11-17

6.  CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.

Authors:  Erica L Johnson; Rajesh Singh; Shailesh Singh; Crystal M Johnson-Holiday; William E Grizzle; Edward E Partridge; James W Lillard
Journal:  World J Surg Oncol       Date:  2010-07-22       Impact factor: 2.754

7.  Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells.

Authors:  Eileen L Heinrich; Amanda K Arrington; Michelle E Ko; Carrie Luu; Wendy Lee; Jianming Lu; Joseph Kim
Journal:  Cancer Microenviron       Date:  2013-02-01

Review 8.  Revisiting the seed and soil in cancer metastasis.

Authors:  Martin Mendoza; Chand Khanna
Journal:  Int J Biochem Cell Biol       Date:  2009-02-03       Impact factor: 5.085

9.  CCL25 Signaling in the Tumor Microenvironment.

Authors:  Hina Mir; Shailesh Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells.

Authors:  Xiaoming Shen; Brian Mailey; Joshua D I Ellenhorn; Peiguo G Chu; Andrew M Lowy; Joseph Kim
Journal:  J Gastrointest Surg       Date:  2009-09-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.